Ackman Is Finally Done With Valeant, Takes $2.8 Billion Loss and Will Step Down From Board

And with a $2.8 billion loss, investor Bill Ackman is done with Valeant Pharmaceuticals. A once staunch defender of the beleaguered company, Ackman said he has sold all of his shares of Valeant stock and will not stand for re-election to the company board of directors.
Source link